Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Type 1 Diabetes · Diabetes Mellitus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
Contact: Study coordinator (Gabrielle Kemp, DEC Nursing) · gabrielle.kemp@rimuhc.ca · (438) 886-2171
Contact: Study coordinator (Michael Tsoukas, MD)
Contact: Study coordinator (Ahmad Haidar, Ph.D)
Contact: Study coordinator (Vanessa Tardio, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes

Diabetes

Abroad (travel likely)RecruitingPHASE2

Tanta, Egypt

Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes

Type 1 Diabetes Mellitus

Abroad (travel likely)RecruitingPHASE2, PHASE3

Nanjing, China

Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM

Type 1 Diabetes Mellitus

Abroad (travel likely)Recruiting

Escondido, United States · Walnut Creek, United States

Societal Burden Associated With Type 1 Diabetes in Canada

Type 1 Diabetes Mellitus · Quality of Life (QOL) · Work Productivity

Abroad (travel likely)Recruiting

Montreal, Canada